Roberto Llarena

Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial

Alfonso Gómez‐Iturriaga, F. Casquero, A. Urresola et al. · Radiotherapy and Oncology · 2016 · 77 citations

Health Sciences, Dose Escalation, Brachytherapy +6

Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma

José I. López, Peio Errarte, Asier Erramuzpe et al. · Human Pathology · 2016 · 60 citations

Tumor Biology, Urology, Genitourinary Cancer +8

Improved Prediction of Biochemical Recurrence After Radical Prostatectomy by Genetic Polymorphisms

Juan Moróte, Jokin del Amo, Ángel Borque‐Fernando et al. · The Journal of Urology · 2010 · 32 citations

Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer

Caroline E. Nunes‐Xavier, Wanja Kildal, Andreas Kleppe et al. · The Prostate · 2021 · 24 citations · Full text

Androgen Receptor, Poor Outcome, Immunology +16

Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer

Caroline E. Nunes‐Xavier, Maite Emaldi, Ingrid Jenny Guldvik et al. · Pathology - Research and Practice · 2022 · 23 citations · Full text